CLINICAL_TRIALS
trial_result
· 2013-12-24
Clinical Trial Update: A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine [Phase 4]
Summary
Phase 4 trial comparing 8 mg to 4 mg fesoterodine for overactive bladder has completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Overactive Bladder | Phase 4 | Status: COMPLETED | Results posted: 2013-12-24